Characteristics of patients with columnar-lined Barrett's esophagus and risk factors for progression to esophageal adenocarcinoma

World Journal of Gastroenterology

Volumn 11, Issue 43, 2005, Pages 6807-6814

  Bani Hani, Kamal E ^a   Bani Hani, Bayan K ^a   Martin, Iain G ^b  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Adenocarcinoma; Barrett's esophagus; Esophageal adenocarcinoma; Esophageal stricture; Risk factors

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BARRETT ESOPHAGUS; CARCINOGENESIS; CHILD; DISEASE COURSE; DRINKING BEHAVIOR; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGITIS; ESOPHAGUS STRICTURE; ESOPHAGUS ULCER; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING; SYMPTOM;

EID: 30744442772     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i43.6807     Document Type: Article

References (67)

1. Stein HJ, Siewert JR. Barrett's esophagus: pathogenesis, epidemiology, functional abnormalities, malignant degeneration, and surgical management. Dysphagia 1993; 8: 276-288
2. Naef AP, Savary M, Ozzello L. Columnar-lined lower esophagus: an acquired lesion with malignant predisposition Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas. J Thorac Cardiovasc Surg 1975; 70: 826-835
3. Bartlesman JF, Hameeteman W, Tytgat GN. Barrett's oesophagus. Eur J Cancer Prev 1992; 1: 323-325
4. Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 1990; 99: 918-922
5. Spechler SJ. Endoscopic surveillance for patients with Barrett's esophagus: Does the cancer risk justify the practice? Ann Intern Med 1987; 106: 902-904
6. Spechler SJ. Endoscopic surveillance for patients with Barrett esophagus: does the cancer risk justify the practice? Ann Intern Med 1987; 106: 649-654
7. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985; 313: 857-859
8. Cameron AJ, Ott BJ Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985; 313: 541-544
9. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287-1289
10. Macdonald CE, Wicks AC, Playford RJ. Ten years' experience of screening patients with Barrett's oesophagus in a university teaching hospital. Gut 1997; 41: 303-307
11. Cameron AJ, Lomboy CT. Barrett's esophagus: age, prevalence, and extent of columnar epithelium. Gastroenterology 1992; 103: 1241-1245
12. Borrie J, Goldwater L. Columnar cell-lined esophagus: assessment of etiology and treatment. A 22 year experience. J Thorac Cardiovasc Surg 1976; 71: 825-834
13. Wright TA, Gray MR, Morris AI, Gilmore IT, Ellis A, Smart HL, Myskow M, Nash J, Donnelly RJ, Kingsnorth AN. Cost effectiveness of detecting Barrett's cancer. Gut 1996; 39: 574-579
14. Menke-Pluymers MB, Hop WC, Dees J, van Blankenstein M, Tilanus HW. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group. Cancer 1993; 72:1155-1158
15. Sjogren RW Jr, Johnson LF. Barrett's esophagus: a review. Am J Med 1983; 74: 313-321
16. Robertson CS, Mayberry JF, Nicholson DA, James PD, Atkinson M. Value of endoscopic surveillance in the detection of neoplastic change in Barren's oesophagus. Br J Surg 1988; 75: 760-763
17. Achkar E, Carey W. The cost of surveillance for adenocarcinoma complicating Barrett's esophagus. Am J Gastroenterol 1988; 83: 291-294
18. Rogers EL, Goldkind SF, Iseri OA, Bustin M, Goldkind L, Hamilton SR, Smith RL. Adenocarcinoma of the lower esophagus. A disease primarily of white men with Barrett's esophagus. J Clin Gastroenterol 1986; 8: 613-618
19. Gopal DV, Lieberman DA, Magaret N, Fennerty MB, Sampliner RE, Garewal HS, Falk GW, Faigel DO. Risk factors for dysplasia in patients with Barrett's esophagus (BE): results from a multicenter consortium. Dig Dis Sci 2003; 48: 1537-1541
20. Skinner DB, Walther BC, Riddell RH, Schmidt H, Iascone C, DeMeester TR. Barrett's esophagus. Comparison of benign and malignant cases. Ann Surg 1983; 198: 554-566
21. Schnell TG, Sontag SJ, Chejfec G. Adenocarcinomas arising in tongues or short segments of Barrett's esophagus. Dig Dis Sci 1992; 37: 137-143
22. Cameron AJ, Lomboy CT, Pera M, Carpenter HA. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995; 109: 1541-1546
23. Schnell T, Sontag S, Chejfec G, Miller T, Kurucar C, O'Connell S, Brand L. Does length (L) of Barrett's esophagus (BE) correlate with age, cigarette or alcohol consumption or risk of adenocarcinoma (adCa) (abstract)? Gastroenterology 1990; 98: A120.
24. Iftikhar SY, James PD, Steele RJ, Hardcastle JD, Atkinson M. Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut 1992; 33: 1155-1158
25. Clark GW, Smyrk TC, Burdiles P, Hoeft SF, Peters JH, Kiyabu M, Hinder RA, Bremner CG, DeMeester TR. Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg 1994; 129: 609-614
26. Avidan B, Sonnenberg A, Schnell TG, Chejfec G, Metz A, Sontag SJ. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma. Am J Gastroenterol 2002; 97: 1930-1936
27. Weston AP, Badr AS, Hassanein RS. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Am J Gastroenterol 1999; 94: 3413-3419
28. Rudolph RE, Vaughan TL, Storer BE, Haggitt RC, Rabinovitch PS, Levine DS, Reid BJ. Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus. Ann Intern Med 2000; 132: 612-620
29. Van der Veen AH, Dees J, Blankensteijn JD, Van Blankenstein M. Adenocarcinoma in Barrett's oesophagus: an overrated risk. Gut 1989; 30: 14-18
30. Moghissi K, Sharpe DA, Pender D. Adenocarcinoma and Barrett's oesophagus. A clinico-pathological study. Eur J Cardiothorac Surg 1993; 7: 126-131
31. Lerut T, Coosemans W, Van Raemdonck D, Dillemans B, De Leyn P, Mamette JM, Geboes K. Surgical treatment of Barrett's carcinoma. Correlations between morphologic findings and prognosis. J Thorac Cardiovasc Surg 1994; 107: 1059-65; discussion 1065-1066
32. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-831
33. Brown LM, Swanson CA, Gridley G, Swanson GM, Schoenberg JB, Greenberg RS, Silverman DT, Pottern LM, Hayes RB, Schwartz AG. Adenocarcinoma of the esophagus: role of obesity and diet. J Natl Cancer Inst 1995; 87: 104-109
34. Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 1999; 130: 883-890
35. Gray MR, Donnelly RJ, Kingsnorth AN. The role of smoking and alcohol in metaplasia and cancer risk in Barrett's columnar lined oesophagus. Gut 1993; 34: 727-731
36. ALLISON PR, JOHNSTONE AS. The oesophagus lined with gastric mucous membrane. Thorax 1953; 8: 87-101
37. Haggitt RC, Tryzelaar J, Ellis FH, Colcher H. Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. Am J Clin Pathol 1978; 70: 1-5
38. Chow WH, Finley WD, McLaughlin JK, Frankl H, Ziel HK, Fraumeni JF Jr. The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA 1995; 274: 474-477
39. van der Burgh A, Dees J, Hop WC, van Blankenstein M. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. Gut 1996; 39: 5-8
40. Hamilton SR, Smith RR, Cameron JL. Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol 1988; 19: 942-948
41. Harle IA, Finley RJ, Belsheim M, Bondy DC, Booth M, Lloyd D, McDonald JW, Sullivan S, Valberg LS, Watson WC, et al. Management of adenocarcinoma in a columnar-lined esophagus. Ann Thorac Surg 1985; 40: 330-336
42. Rosenberg JC, Budev H, Edwards RC, Singal S, Steiger Z, Sundareson AS. Analysis of adenocarcinoma in Barrett's esophagus utilizing a staging system. Cancer 1985; 55: 1353-1360
43. Levine DS, Haggitt RC, Blount PL, Rabinovitch PS, Rusch VW, Reid BJ. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 1993; 105: 40-50
44. Sharma P. Short segment Barrett esophagus and specialized columnar mucosa at the gastroesophageal junction. Mayo Clin Proc 2001; 76: 331-334
45. Reynolds JC, Rahimi P, Hirschl D. Barrett's esophagus: clinical characteristics. Gastroenterol Clin North Am 2002; 31: 441-460
46. Gammon MD, Schoenberg JB, Ahsan H, Risch HA, Vaughan TL, Chow WH, Rotterdam H, West AB, Dubrow R, Stanford JL, Mayne ST, Farrow DC, Niwa S, Blot WJ, Fraumeni JF Jr. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1997; 89: 1277-1284
47. Garidou A, Tzonou A, Lipworth L, Signorello LB, Kalapothaki V, Trichopoulos D. Life-style factors and medical conditions in relation to esophageal cancer by histologic type in a low-risk population. Int J Cancer 1996; 68: 295-299
48. Zhang ZF, Kurtz RC, Sun M, Karpeh M Jr, Yu GP, Gargon N, Fein JS, Georgopoulos SK, Harlap S. Adenocarcinomas of the esophagus and gastric cardia: medical conditions, tobacco, alcohol, and socioeconomic factors. Cancer Epidemiol Biomarkers Prev 1996; 5: 761-768
49. Kabat GC, Ng SK, Wynder EL. Tobacco, alcohol intake, and diet in relation to adenocarcinoma of the esophagus and gastric cardia. Cancer Causes Control 1993; 4: 123-132
50. Spechler SJ, Robbins AH, Rubins HB, Vincent ME, Heeren T, Doos WG, Colton T, Schimmel EM. Adenocarcinoma and Barrett's esophagus. An overrated risk? Gastroenterology 1984; 87: 927-933
51. Avidan B, Sonnenberg A, Schnell TG, Sontag SJ. Hiatal hernia and acid reflux frequency predict presence and length of Barrett's esophagus. Dig Dis Sci 2002; 47: 256-264
52. Conio M, Filiberti R, Blanchi S, Ferraris R, Marchi S, Ravelli P, Lapertosa G, Iaquinto G, Sablich R, Gusmaroli R, Aste H, Giacosa A. Risk factors for Barrett's esophagus: a case-control study. Int J Cancer 2002; 97: 225-229
53. Gronbaek M, Becker U, Johansen D, Tonnesen H, Jensen G, Sorensen TI. Population based cohort study of the association between alcohol intake and cancer of the upper digestive tract. BMJ 1998; 317: 844-847
54. Cooper BT, Barbezat GO. Barrett's oesophagus: a clinical study of 52 patients. Q J Med 1987; 62: 97-108
55. Levi F, Ollyo JB, La Vecchia C, Boyle P, Monnier P, Savary M. The consumption of tobacco, alcohol and the risk of adenocarcinoma in Barren's oesophagus. Int J Cancer 1990; 45: 852-854
56. Herlihy KJ, Orlando RC, Bryson JC, Bozymski EM, Carney CN, Powell DW. Barrett's esophagus: clinical, endoscopic, histologic, manometric, and electrical potential difference characteristics. Gastroenterology 1984; 86: 436-443
57. Day NE, Munoz N. Esophagus. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiology and prevention Philadelphia: WB Saunders Co, 1982: 596-623
58. Goldman MC, Beckman RC. Barren syndrome. Case report with discussion about concepts of pathogenesis. Gastroenterology 1960; 39: 104-110
59. Halvorsen JF, Semb BK. The "Barrett syndrome" (the columnar-lined lower oesophagus): an acquired condition secondary to reflux oesophagitis. A case report with discussion of pathogenesis. Acta Chir Scand 1975; 141: 683-687
60. Jankowski J. Gene expression in Barrett's mucosa: acute and chronic adaptive responses in the oesophagus. Gut 1993; 34: 1649-1650
61. Morgan G, Vainio H. Barrett's oesophagus, oesophageal cancer and colon cancer: an explanation of the association and cancer chemopreventive potential of non-steroidal antiinflammatory drugs. Eur J Cancer Prev 1998; 7: 195-199
62. Heath EI, Limburg PJ, Hawk ET, Forastiere AA. Adenocarcinoma of the esophagus: risk factors and prevention. Oncology (Williston Park) 2000; 14: 507-14; discussion 518-520, 522-523
63. Paull G, Yardley JH. Gastric and esophageal Campylobacter pylori in patients with Barrett's esophagus. Gastroenterology 1988; 95: 216-218
64. Talley NJ, Cameron AJ, Shorter RG, Zinsmeister AR, Phillips SF. Campylobacter pylori and Barrett's esophagus. Mayo Clin Proc 1988; 63: 1176-1180
65. Weston AP, Badr AS, Topalovski M, Cherian R, Dixon A, Hassanein RS. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma. Am J Gastroenterol 2000; 95: 387-394
66. Bani-Hani K, Martin IG, Hardie LJ, Mapstone N, Briggs JA, Forman D, Wild CP. Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma. J Natl Cancer Inst 2000; 92: 1316-1321
67. Wild CP, Forman D. Surveillance for Barrett's oesophagus. It is too early to dismiss surveillance programmes. BMJ 2001; 322: 1125; author reply 1126